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Abstract
Background: Persons who use opioids have a high risk of overdose and associated mortality. In Vietnam, little is
known about the characteristics of this population and the persons who are witness to those overdoses. One approach
to combatting fatal overdose has been the use of peer interventions in which a friend or injecting partner administers
overdose reversal medication, but availability in Vietnam of these medications is limited to pilot programs with aims to
expand in the future (Le Minh and V.F. Go, Personal Communication, 2016). The primary objective of this paper is to
explore the characteristics associated with witnessing three or more overdoses in a lifetime.
Methods: This cross-sectional analysis used baseline data from a four-arm randomized control trial conducted in Thai
Nguyen, Vietnam, known as the Prevention for Positives project. One thousand six hundred seventy-three PWID were
included in the analysis. We conducted bivariable and multivariable logistic regression to identify characteristics
associated with witnessing three or more overdoses in a lifetime. Characteristics explored included education,
employment, marital status, risky drug use behaviors, locations for accessing syringes, recent overdose, history of
incarceration, drug treatment, and having slept outside in the past 3 months.
Results: Seventy-two percent (n = 1203) of participants had witnessed at least one overdose in their lifetime, and 46%
had witnessed three or more overdoses (n = 765). In the multivariable model, having less than secondary education
(AOR 0.70; 95% CI 0.57, 0.86), having slept outside in the past 3 months (AOR 1.77; 95% CI 1.31, 2.40), having a history of
incarceration (AOR 1.33; 95% CI 1.07, 1.65), having a history of drug treatment (AOR 1.41; 95% CI 1.12, 1.77), experiencing
a recent non-fatal overdose (AOR 3.84; 95% CI 2.36, 6.25), injecting drugs daily (AOR 1.79; 95% CI 1.45, 2.20), receptive
needle sharing (AOR 1.30; 95% CI 1.04, 1.63), and number of years injecting (AOR 1.04; 95% CI 1.02, 1.07) were
significantly associated with witnessing three or more overdoses.
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Conclusions: Targeted interventions are needed to train persons witnessing an overdose to administer overdose-
reversal medication. This includes targeting persons prior to release from prisons, drug treatment centers, and those
accessing syringe exchange programs. Additional research should assess the burden of witnessing an overdose as well
as locations for medication distribution. Assessments of the training capacity and needs for implementing these
programs among drug using peers in Vietnam are of the utmost importance.
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Background
Overdoses from opioids are a global problem. The
United Nations on Drugs and Crime (UNODC) has
noted that 33 million people use opioids. When exclud-
ing people who abuse prescribed opioids, an issue largely
isolated to North America, 17 million people in the
world use opioids and approximately two thirds of those
individuals live in Asia [1]. An opioid overdose can lead
to death as well as other morbidities including brain
damage [2].
Most of the world’s opium production occurs in south-
west and southeast Asia. In much of Asia, the most
commonly used opiate is heroin [1]. Asia has one of the
highest crude mortality rates among opioid-using indi-
viduals of any region in the world with an estimated
5.23 deaths per 100 person-years [3]. Opioid overdose
prevalence estimates are limited in large part because of
the hard-to-reach drug using population. Many over-
doses are never reported as people who witness an over-
dose often do not contact health authorities due to fear
of arrest for drug-using behavior [4, 5].
The UNODC and the World Health Organization
have recommended distribution of opioid-reversal drugs
to persons who inject and their family and friends [2, 6].
Peer-based interventions are needed, as most opioid
overdoses occur in the presence of other persons who
inject drugs (PWID) [7, 8]. Opioid-reversal drugs,
known as naloxone, prevent death effectively. Naloxone
exists as both an injection and as a nasal spray, though
in Vietnam only the injection version is currently avail-
able. Most often, people administer naloxone by injec-
tion; therefore, effective overdose prevention programs
require a hands-on training [9]. A possible criticism of
this approach is the concerns of non-medical personnel
in using a syringe when administering the drug. How-
ever, if the people who use drugs are trained in recogniz-
ing overdose and administering naloxone, they are just
as successful in reversing overdoses as medical profes-
sionals [7]. There are few contraindications for adminis-
tering naloxone; persons who are administered the
opioid receptor antagonist experience few side effects.
Even when a person administers naloxone to someone
they believe to be experiencing an opioid overdose but is
not, the drug has a low likelihood of negative health
effects [10]. In addition, naloxone distribution programs
that target people who use opioids and family members
of those who have a history of overdose from opioids are
cost-effective [11].
The World Health Organization recommends providing
naloxone to those who are likely to witness an overdose
[2, 12]. However, naloxone distribution and other over-
dose prevention interventions have historically focused on
medical personnel and only recently have begun to imple-
ment programs with drug using peers and/or family mem-
bers [13]. In Vietnam, naloxone availability currently is
limited to a few pilot programs in Hanoi and Ho Chi
Minh City, with plans to expand naloxone programs in
the near future [14]. To inform scale up efforts through-
out Vietnam, we sought to define the characteristics of po-
tential administrators of naloxone: PWID who have
witnessed three or more overdoses. In doing so, we aim to
identify populations to focus on for implementation of
overdose prevention interventions in Vietnam.
Methods
Study location
Participants were recruited in Thai Nguyen, a northeast-
ern province of Vietnam approximately 80 km north of
the capital city Hanoi near the border with China. Re-
cent estimates suggest about 6000 PWID live in this part
of Vietnam [15]. The most frequently used drug in this
area is heroin. Heroin is inexpensive in Vietnam and
readily available in this part of the world because of the
geographic location of the trade route from the Golden
Triangle [4].
Study design and study population characteristics
This cross-sectional analysis used baseline data collected
as part of a four-arm randomized control trial known as
the Prevention for Positives project. The parent trial
evaluated the effectiveness of a multi-level intervention
to reduce high-risk injecting and sexual practices among
HIV-positive PWID in order to reduce forward HIV
transmission. Details of this trial are described elsewhere
[16], but briefly, participants were recruited through
peer referral in which a team of seven current and
former drug users approached their drug networks with
information about the trial and referred them for
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screening. Inclusion criteria for the trial included (1) be-
ing male, (2) being 18 years old, (3) being sexually active
in the past 6 months, (4) having self-reported injection
drug use in the past 6 months, and (5) being able to pro-
vide informed consent. A total of 1739 PWID were
screened and 1674 deemed eligible and consented for
participation in the baseline interview. Trained study
staff administered a 1-h face-to-face interview using a
questionnaire that included questions on demographic
characteristics, sexual risk behaviors, drug use behaviors
including equipment sharing, and stigma regarding areas
such as HIV and injection drug use. Not all participants
who completed the questionnaire completed the full trial
but are included in this cross-sectional analysis. All par-
ticipants received 75,000 Vietnamese Dong ($3.50 USD)
as well as reimbursement for the cost of travel to the
study site. This research protocol was approved by the
Thai Nguyen Center for Preventive Medicine Institu-
tional Review Board and Johns Hopkins Institutional
Review Board.
Measures
The dependent variable for this analysis is having ever
witnessed three or more overdoses. Prior to answering
questions about history of witnessing an overdose, inter-
viewers provided a definition of overdose: “Drug over-
dose happens when an individual takes more drugs than
the body can handle. When an individual overdoses on a
drug, he may have some of the following symptoms:
throwing-up, face turning pale, unable to talk, slow and
erratic heartbeats, slow and shallow breathing, losing
consciousness, etc.” After assessing the frequency and
distribution of overdoses, we selected witnessing three
or more overdoses as we found that among those wit-
nessing at least one, almost half (46%) had witnessed
three or more; other studies have noted that these
people who report a history of being witness to more
than one overdose are more likely to witness a future
overdose [17, 18]. We first defined this variable using
the survey question, “In your lifetime, how many people
have you witnessed having an overdose (not including
yourself )?” Those who responded with three or more
were coded as “yes” to having witnessed three or more
overdoses in their lifetimes and those who responded
with zero, one, or two were coded as “no” for having
witnessed three or more overdoses in their lifetimes.
We identified the primary independent variables for
this analysis from the overdose literature and from our
own hypotheses based on our conceptualization of wit-
nessing an overdose. We assessed recent experience of
an overdose (How many different times in the past
12 months have you overdosed?). Those who responded
with one or more were coded as “yes” to having experi-
enced a recent overdose and those who responded with
zero were coded as “no” for having experienced a recent
overdose [17]. Important for populations of PWID, we
determined additional key independent variables for ana-
lysis including history of incarceration (Have you ever
been incarcerated (that is being put in prison or jail or
detention center)?) [18] as well as having slept outside in
the past 3 months based on literature around homeless-
ness and housing instability in drug-using populations
[19] (During the last 3 months have you ever spent a
night on the street, in a park, in an alley, or in an aban-
doned building?).
We hypothesized that high-risk drug use behaviors
such as daily injecting of drugs and using a needle after
someone else (receptive needle sharing) would be associ-
ated with having been a witness to an overdose [20]. We
included a history of drug treatment (Have you ever
been in a drug treatment program?) because drug treat-
ment can often be mandated as part of legal punishment
of illicit drug use [16].
We also captured data on location of needles pur-
chased in the past 3 months, including pharmacies
which are the dominant location for inexpensive clean
needle purchases in Thai Nguyen [16]. We hypothe-
sized that individuals who did not obtain their needles
from a pharmacy may be engaging in riskier drug use
behaviors and therefore more likely to have witnessed
three or more overdoses. Additionally, we included the
number of years a person reported injecting drugs since
those who have injected drugs longer may have an in-
creased likelihood for being a witness to an overdose
[18]. Other demographic variables included education
(less than a high school education versus more than a
high school education), marital status (married or living
with partner versus not married or living with partner),
and employment status (full-time employment being
30 h a week or more).
Statistical analyses
The full sample of participants was 1674. We removed
one person from the analysis because of their response
to the primary outcome, having ever witnessed an over-
dose, being “Don’t Know,” and thus had a remaining
sample of 1673. We calculated frequency distributions
for categorical variables and medians and inter-quartile
ranges for continuous variables. We conducted bivari-
able logistic regression to estimate unadjusted odds ra-
tios and 95% confidence intervals and for characteristics
associated with those having witnessed three or more
overdoses in their lifetimes; we determined that the high
proportion of the population having been witness to
three or more overdoses warranted further exploration.
To estimate adjusted odds ratios and 95% confidence
intervals, we utilized simultaneous entry for all variables
associated with witnessing three or more overdoses in
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bivariable analyses, using a p value of < 0.10. We also in-
cluded characteristics previously identified in the litera-
ture as significant among this population having
witnessed three or more overdoses. Additionally, we
controlled for age in the multivariable analysis because
witnessing an overdose, both fatal and non-fatal, has
been associated with increasing age [21, 22]. We ad-
justed for drug treatment in this final adjusted model
recognizing that the directionality of the relationship of
history of drug treatment has been more difficult to tease
apart since it has been hypothesized that individuals may
seek treatment after witnessing an overdose [17]. For inde-
pendent variables with a response of “Don’t Know,” we
coded these as missing and did not include them in the
analysis. Characteristics with a p value of < 0.05 in the
final adjusted model were considered independently
associated with having witnessed three or more overdoses.
We used Pearson’s correlation coefficient to assess
collinearity of all independent and dependent variables
prior to testing the full adjusted model.
Results
Participant characteristics
We sampled 1673 participants. The median age was 36
(IQR 28–44), and half reported being married or living
with a partner (Table 1). Most reported full-time em-
ployment (73.9%). More than half reported injecting
drugs on a daily basis (51.3%), and most reported pur-
chasing their needles from a pharmacy (86.7%). About
one third of the sample reported having been in a drug
treatment program (30.7%), and similarly, more than
one third of the sample reported having ever been
incarcerated (35.0%).
Associations with having witnessed three or more overdoses
More than two thirds of the total sample reported wit-
nessing at least one overdose (71.9%), 1057 persons wit-
nessed two or more overdoses (63.2%), and 765 persons
reported witnessing three or more overdoses in their
lifetimes (45.7%) (Fig. 1). Of the 765 people who re-
ported witnessing three or more overdoses, 47.3% were
married and living with a partner and 58.0% had less
than a high school education.
In bivariable analyses, those who witnessed three or
more overdoses had higher odds of experiencing a re-
cent overdose themselves (OR 4.30; 95% CI 2.70, 6.86),
of reporting having slept outside in the past 3 months
(OR 2.17; 95% CI 1.65, 2.87), of having ever been incar-
cerated (OR 1.64; 95% CI 1.34, 2.01), of having ever been
in drug treatment (OR 1.75, 95% CI 1.42, 2.16), of inject-
ing drugs daily (OR 2.07; 95% CI 1.70, 2.52), of engaging
in receptive needle sharing behavior (OR 1.45; 95% CI
1.18, 1.78), and of having a longer injecting history (OR
1.07; 95% CI 1.04–1.09) (Table 2). Those who had
witnessed three or more overdoses had lower odds of
being employed full-time (OR 0.75; 95% CI 0.60–0.93)
and having less than a high school education (OR 0.66;
95% CI 0.55, 0.81) than those who had witnessed fewer
than three overdoses.
In multivariable analysis (Table 2), variables that
remained significant in the adjusted model after control-
ling for age included having slept outside in the past
3 months (AOR 1.77; 95% CI 1.31, 2.40), history of drug
treatment (AOR 1.41; 95% CI 1.12, 1.77), receptive nee-
dle sharing behavior (AOR 1.30, 95% CI 1.04, 1.63), and
years injecting (AOR 1.04; 95% CI 1.02, 1.07). History of
incarceration was also significant in the full model (AOR
1.33; 95% CI 1.07, 1.65). Individuals who had less than
high school education (AOR 0.77; 95% CI 0.62, 0.96)
were less likely to witness three or more overdoses.
Employment was not significant in the full model.
Discussion
Almost half of our sample had witnessed three or more
drug overdoses and more than 70% had witnessed at
least one, mirroring worldwide estimates [23]. Those
who reported receptive needle sharing were more likely
to witness three or more overdoses, and more than half
of the sample witnessing three or more overdoses re-
ported injecting drugs on a daily basis. These character-
istics suggest a population engaging in high-risk drug
use behavior and doing so with other PWID. We found
people who had recently overdosed themselves were
more likely to witness three or more overdoses. Over-
dose has historically been explored as an individual ex-
perience and problem, but recent recommendations
from WHO and UNODC to distribute naloxone to the
family and friends of PWID [24] suggest a changing ap-
proach. These recommendations to address the more so-
cial aspect of overdose must be coupled with research to
better understand the social context in which individuals
inject drugs. PWID who overdose are also more likely to
be with another partner or group when the event occurs
[25]. Most overdose deaths do not occur instantan-
eously, suggesting there is a window of time in which
peers witness to the overdose, can recognize symptoms,
and administer naloxone [26].
In addition to high-risk drug use behaviors, our ana-
lyses found that those persons who reported sleeping
on the street in the past 3 months were more likely to
witness three or more overdoses. In a 2015 study
among younger PWID in Hanoi, Vietnam, nearly 10%
reported living on the street with another 19% report-
ing temporary housing [25]. Persons who suffer a fatal
overdose are more likely to suffer from instability in
day to day life, such as homelessness [27]. Housing in-
stability may also impact their ability to keep a job or
maintain intimate relationships. Such characteristics
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highlight the challenges in targeting this population
since they may be difficult to reach for interventions
[28, 29]. Our measure asked about sleeping outside in
the past 30 days; thus, measures that can better identify
the type of housing instability and possible
homelessness are needed in order to identify venues for
potential recruitment of people likely to witness three
or more overdoses including centers that provide hous-
ing and services to homeless individuals. Our findings
also suggested that drug treatment centers and prisons
Table 1 Characteristics of persons who inject drugs (PWID) living in Thai Nguyen, Vietnam, in a multi-arm randomized
control trial (n = 1673)
Total study population
(N = 1673)
Witness to 3 or more overdoses
(N = 765)
Witness to less than 3 overdoses
(N = 908)
Baseline characteristics n (%) n (%) n (%)
Age, median (IQR) (years) 36 (28–44) 35 (28–42) 36 (28–44)
Education
High school or more 702 (42.0) 362 (47.3) 340 (37.4)
No high school 971 (58.0) 403 (52.7) 568 (62.6)
Marital status
Not married or living with a partner 853 (51.0) 403 (52.7) 450 (49.6)
Married or living with a partner 820 (49.0) 362 (47.3) 458 (50.4)
Employment status
Less than full-time 436 (26.1) 223 (29.1) 213 (23.5)
Full-time 1237 (73.9) 542 (70.9) 695 (76.5)
Spent the night outside in the past 3 monthsa
No 1428 (85.4) 613 (80.1) 815 (89.8)
Yes 245 (14.6) 152 (19.9) 93 (10.2)
Lifetime history of incarceration
No 1087 (65.0) 450 (58.9) 637 (70.1)
Yes 585 (35.0) 314 (41.1)c 271 (29.9)
Lifetime history of drug treatment
No 1160 (69.3) 481 (62.9) 679 (74.8)
Yes 513 (30.7) 284 (37.1) 229 (25.2)
Recent non-fatal overdoseb
No 1569 (93.8) 685 (89.5) 884 (97.4)
Yes 104 (6.2) 80 (10.5) 24 (2.6)
Daily injecting of drugs
No 815 (48.7) 298 (38.9) 517 (56.9)
Yes 858 (51.3) 467 (61.1) 391 (43.1)
Needle purchasing behavior purchased at a pharmacya
No 222 (13.3) 106 (13.9) 116 (12.8)
Yes 1450 (86.7) 659 (86.1) 791 (87.1)
Don’t Know 1 (0.1) 0 (0.0) 1 (0.1)
Receptive needle sharing behavior
No 1120 (66.9) 478 (62.5) 642 (70.7)
Yes 553 (33.1) 287 (37.5) 266 (29.3)
Lifetime number of years injecting drugs, median
(IQR) (years)d
8 (4–12) 9 (5–13) 7 (3–11)
IQR interquartile range
aPast 3 months
bPast 12 months
cOne individual missing information about incarceration history
dThirteen responses “Don’t Know” (n = 1613)
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may be possible venues for reaching individuals likely
to witness three or more overdoses.
In Vietnam, some non-profit organizations have begun
to distribute naloxone to non-medical professionals and
the general population as part of pilot programs [14].
Needle and syringe exchange programs (NSPs) are also
possible locations for distributing naloxone to those who
are injecting drugs daily [30]. During the time of data
collection, there were 16 needle exchange sites operating
in Thai Nguyen [16], thus a possible avenue for distribu-
tion in the province. The majority of participants in our
sample reported using pharmacies for accessing syringes,
which we attribute to the fact that pharmacies sell clean
needles inexpensively and are readily available through-
out the province. An option that has been explored in
parts of North America is to distribute naloxone through
pharmacies [13]. In the USA, programs using pharma-
cists as the source of opioid overdose prevention pro-
grams are expanding, using the healthcare system as the
avenue for distribution of naloxone [13, 30]. However,
our analyses did not find a significant relationship be-
tween buying needles from a pharmacy and being a wit-
ness to three or more overdoses. Indeed, we found that
those who bought needles at pharmacies engaged in
lower risk drug use behavior compared to those who did
not access pharmacies. Other research suggest that phar-
macies are a good avenue for syringe distribution to
PWID [31]; therefore, pharmacies may be a good area
for research in overdose prevention in Vietnam.
As distribution of overdose-reversal drugs are ex-
panded in Vietnam, interventions to train drug users on
how to recognize an overdose, how to distribute nalox-
one, and how to administer it will need to be developed
[9]. In a recent study in Hanoi, Vietnam, knowledge
about overdose, including how to identify someone ex-
periencing an overdose and what steps to take to pre-
vent death from an overdose, varied greatly [4]. The
development and implementation of these trainings in
Vietnam would support recent recommendations from
the World Health Organization that countries should
expand access to naloxone so that laypersons could ac-
quire it [2]. In the USA, researchers have developed the
Opioid Overdose Knowledge scale which supports the
training of family members and peers of drug users to
administer naloxone [32]. Adaptation of this scale for
the Vietnamese setting may support the effectiveness of
the trainings in naloxone. Research and further training
on overdose prevention should also incorporate where
the overdoses are most frequently occurring. US-based
studies have found that overdoses are frequently wit-
nessed at home or in private locations [33, 34]. By iden-
tifying such areas in the Vietnamese context, education
and training could be further tailored to the population
most at risk.
It is important to recognize our limitations from these
analyses. This is a sample of individuals who were resi-
dents of Thai Nguyen, male, reported having injected
drugs, and interested in enrolling into an HIV- and injec-
tion drug use (IDU)-related stigma reduction intervention
study. Individuals referred their peers to the study which
limits our ability to generalize to the larger drug-using
population in Vietnam. Other studies conducted in this
area of Vietnam have found that 97% of PWID are male
[4]. Self-report of witnessing an overdose is an additional
limitation of these data as it may have introduced social
desirability bias as well as recall bias; thus, the number of
individuals who have been a witness to an overdose may
be higher than is presented here. These data are cross-
sectional, and therefore, we are unable to determine tem-
poral relationships with the characteristics associated for
having witnessed an overdose. Specifically, the directional-
ity of the relationship of history of drug treatment has
been more difficult to tease apart since it has been hy-
pothesized that individuals may seek treatment after wit-
nessing an overdose [17]. Additionally, participants only
provided detail on drug treatment if it was in the home or
outside of the home. Information on types of drug treat-
ment received, including methadone, were not collected.
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Conclusions
In Vietnam, individuals who are a witness to three or
more overdoses may have unique characteristics beyond
injecting drugs that public health programs should target
for intervention including having experienced a recent
non-fatal overdose, housing instability, and incarcer-
ation. Collaboration with prisons and drug treatment
centers to conduct trainings on overdose prevention
pre-release is a potential starting point for interventions.
Furthermore, identification of gathering places of those
recently released from prison or those without housing
may help public health officials in Vietnam to identify
populations ideal for opiate overdose prevention inter-
ventions among persons who use drugs.
Table 2 Bivariable and multivariable associations with having witnessed three or more overdoses among individuals injecting drugs
in Thai Nguyen, Vietnam, n = 1673
Characteristic OR (95% CI) p value AORa (95% CI) p value
Education
High school or more 1.00 1.00
No high school 0.66 (0.55–0.81) < 0.01 0.70 (0.57–0.86) < 0.01
Marital status
Not married or living with a partner 1.00
Married or living with partner 0.88 (0.73–1.07) 0.20
Employment Status
Less than full-time 1.00 1.00
Full-time 0.75 (0.60–0.93) 0.01 0.84 (0.66–1.06) 0.1313
Spent the night outside in the past 3 months
Did not spend the night outside 1.00 1.00
Spent the night outside 2.17 (1.65–2.87) < 0.01 1.77 (1.31–2.40) < 0.01
Lifetime history of incarcerationb
No history of incarceration 1.00 1.00
History of incarceration 1.64 (1.34–2.01) < 0.01 1.33 (1.07–1.65) 0.101
Lifetime history of drug treatment
No history of drug treatment 1.00 1.00
History of drug treatment 1.75 (1.42–2.16) < 0.01 1.41 (1.12–1.77) < 0.01
Non-fatal overdose
No recent non-fatal overdose 1.00 1.00
Recent non-fatal overdose 4.30 (2.70–6.86) < 0.01 3.84 (2.36–6.25) < 0.01
Drug injecting frequency
No daily injecting of drugs 1.00 1.00
Daily injecting of drugs 2.07 (1.70–2.52) < 0.01 1.79 (1.45–2.20) < 0.01
Needling purchasing behavior
Did not purchase at a pharmacy 1.00
Purchased at a pharmacyc 0.91 (0.69–1.21) 0.52
Receptive needle sharing behavior
Did not share needles 1.00 1.00
Shared needles 1.45 (1.18–1.78) < 0.01 1.30 (1.04–1.63) 0.02
Lifetime number of years injecting
Years of injecting 1.07 (1.04–1.09) < 0.01 1.04 (1.02–1.07) < 0.01
OR odds ratio, AOR adjusted odds ratio
aAdjusted for age and those variables with p value < 0.10 in bivariable analyses were included in the final multivariable model: education, employment status,
slept outside in the past 3 months, history of incarceration, history of drug treatment, recent non-fatal overdose, daily injecting of drugs, and receptive needle
sharing behavior; n = 1667
bOne response missing (n = 1672)
cOne response “Don’t Know” (n = 1672)
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